Vaccine perspectives for COVID-19 – Interview with Prof. Rino Rappuoli & Prof. Sarah Gilbert
Covid-19 urges policy makers and the big pharma to fasten vaccine developments and possible treatments for the novel coronavirus, SARS-CoV-2. Will the vaccine be specific to Covid-19 only, or will it be suitable for all SARS coronaviruses? Will it be suitable to all ages? What are the greatest challenges of vaccine production processes and why does it take so long?
Ilaria Capua: A preparedness plan against unknown viruses is crucial for Europe
Interview on COVID-19 with Ilaria Capua, DVM, PhD, Director of the One Health Center of Excellence for Research and Training, University of Florida, USA. There are tests for COVID-19 which detects the virus, other which detects antibodies. Could you briefly describe the differences of these two tests? The rapid spread of the outbreak required rapid ...
Helena Legido-Quigley: “Austerity saps the ability of a health system to respond to COVID-19”
Interview on COVID-19 with Helena Legido-Quigley, Associate Professor of Global Health at the London School of Hygiene and Tropical Medicine and at the National University of Singapore. What role has Spain played in the COVID-19 pandemic? Helena Legido-Quigley: Spain has been slow, but as equally slow as the rest of Europe. The continent lost a ...